Introduction
Leiomyosarcoma - Overview
Leiomyosarcoma - Therapeutics Development
Leiomyosarcoma - Therapeutics Assessment
Leiomyosarcoma - Companies Involved in Therapeutics Development
Leiomyosarcoma - Drug Profiles
Leiomyosarcoma - Dormant Projects
Leiomyosarcoma - Discontinued Products
Appendix

List of Tables
Number of Products under Development for Leiomyosarcoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Leiomyosarcoma - Pipeline by Advenchen Laboratories LLC, H1 2020
Leiomyosarcoma - Pipeline by ALX Oncology Inc, H1 2020
Leiomyosarcoma - Pipeline by Apexigen Inc, H1 2020
Leiomyosarcoma - Pipeline by Apollomics Inc, H1 2020
Leiomyosarcoma - Pipeline by AstraZeneca Plc, H1 2020
Leiomyosarcoma - Dormant Projects, H1 2020
Leiomyosarcoma - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Leiomyosarcoma, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• Advenchen Laboratories LLC
• ALX Oncology Inc
• Apexigen Inc
• Apollomics Inc
• AstraZeneca Plc
• Atara Biotherapeutics Inc
• BeiGene Ltd
• BioMed Valley Discoveries Inc
• Cell Medica Ltd
• CStone Pharmaceuticals Co Ltd
• Eli Lilly and Co
• ENB Therapeutics LLC
• Exelixis Inc
• F. Hoffmann-La Roche Ltd
• Incyte Corp
• Karyopharm Therapeutics Inc
• Merck & Co Inc
• Merck KGaA
• Millennium Pharmaceuticals Inc
• Nektar Therapeutics
• Ono Pharmaceutical Co Ltd
• Pfizer Inc
• PTC Therapeutics Inc
• Tactical Therapeutics Inc
• Vicus Therapeutics LLC
• Y-mAbs Therapeutics Inc
• Yooyoung Pharm Co Ltd